Wei-Ching Liang Selected Research

Wei-Ching Liang Research Topics

12	Neoplasms (Cancer) 01/2021 - 07/2004
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 12/2015
2	Breast Neoplasms (Breast Cancer) 06/2015 - 09/2008
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Bites and Stings (Sting) 01/2020
1	Disease Progression 01/2020
1	Geographic Atrophy 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Neuroblastoma 09/2008
1	Neoplasm Metastasis (Metastasis) 04/2008
1	Vascular Remodeling 01/2007
1	Colorectal Neoplasms (Colorectal Cancer) 03/2006
1	Fibrosarcoma 07/2004
1	Carcinogenesis 07/2004

7	AntibodiesIBA 01/2021 - 01/2006
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008 - 07/2004
3	Monoclonal AntibodiesIBA 09/2012 - 07/2004
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2015
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 06/2015
2	Neuropilin-1IBA 09/2012 - 01/2007
2	Blocking AntibodiesIBA 02/2007 - 01/2006
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Interferon Type IIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Biological ProductsIBA 01/2020
1	HydrolasesIBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	TrypsinIBA 12/2015
1	Serine Proteases (Serine Protease)IBA 12/2015
1	vesencumabIBA 09/2012
1	Insulin-Like PeptidesIBA 09/2008
1	Docetaxel (Taxotere)FDA Link 09/2008
1	Antineoplastic Agents (Antineoplastics)IBA 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2008
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2008
1	LigandsIBA 09/2008
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2008
1	Neuropilin-2IBA 04/2008
1	Vascular Endothelial Growth Factor CIBA 04/2008
1	Bevacizumab (Avastin)FDA Link 01/2006
1	Chemotactic FactorsIBA 07/2004
1	platelet-derived growth factor AIBA 07/2004
1	Immunoglobulin G (IgG)IBA 07/2004

4	Therapeutics 01/2020 - 01/2007
3	Immunotherapy 01/2021 - 01/2020